Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c05456 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Lucheng Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 1 Bei-Er-Jie Street, Haidian District…. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 1 Bei-Er-Jie Street, Haidian District, Beijing 100190, China.
- University of Chinese Academy of Sciences, 19 Yuquan Road, Shijingshan District, Beijing 100049, China.
ORCID-Profile: Tao Hu
Förderung
- National Key Research and Development Program of China
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Xiao, L., Yu, W., Shen, L., Yan, W., Qi, J., & Hu, T. (2023). Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c05456
Vancouver
Xiao L, Yu W, Shen L, Yan W, Qi J, Hu T. Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c05456
BibTeX
@article{Xiao2023,
author = {Xiao, Lucheng and Yu, Weili and Shen, Lijuan and Yan, Wenying and Qi, Jinming and Hu, Tao},
title = {Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c05456}
}
EUVIMED